These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 9681328)
1. CEDIA dau Benzodiazepine screening assay: a reformulation. Meatherall RC; Fraser AD J Anal Toxicol; 1998; 22(4):270-3. PubMed ID: 9681328 [TBL] [Abstract][Full Text] [Related]
2. Improved cross-reactivity to alpha OH triazolam in the BMC CEDIA DAU urine benzodiazepine assay. Fraser AD; Meatherall R Ther Drug Monit; 1998 Jun; 20(3):331-4. PubMed ID: 9631932 [TBL] [Abstract][Full Text] [Related]
3. Comparison of four immunoassays for the detection of lorazepam in urine. Meatherall R; Fraser AD Ther Drug Monit; 1998 Dec; 20(6):673-5. PubMed ID: 9853986 [TBL] [Abstract][Full Text] [Related]
4. Urine benzodiazepine screening using Roche Online KIMS immunoassay with beta-glucuronidase hydrolysis and confirmation by gas chromatography- mass spectrometry. Klette KL; Wiegand RF; Horn CK; Stout PR; Magluilo J J Anal Toxicol; 2005 Apr; 29(3):193-200. PubMed ID: 15842763 [TBL] [Abstract][Full Text] [Related]
5. KIMS, CEDIA, and HS-CEDIA immunoassays are inadequately sensitive for detection of benzodiazepines in urine from patients treated for chronic pain. Darragh A; Snyder ML; Ptolemy AS; Melanson S Pain Physician; 2014; 17(4):359-66. PubMed ID: 25054395 [TBL] [Abstract][Full Text] [Related]
6. Limitations of EMIT benzodiazepine immunoassay for monitoring compliance of patients with benzodiazepine therapy even after hydrolyzing glucuronide metabolites in urine to increase cross-reactivity: comparison of immunoassay results with LC-MS/MS values. Dixon RB; Floyd D; Dasgupta A Ther Drug Monit; 2015 Feb; 37(1):137-9. PubMed ID: 25004136 [TBL] [Abstract][Full Text] [Related]
7. Comparison of different immunoassays and GC-MS screening of benzodiazepines in urine. Augsburger M; Rivier L; Mangin P J Pharm Biomed Anal; 1998 Dec; 18(4-5):681-7. PubMed ID: 9919969 [TBL] [Abstract][Full Text] [Related]
8. Oxaprozin cross-reactivity in three commercial immunoassays for benzodiazepines in urine. Fraser AD; Howell P J Anal Toxicol; 1998; 22(1):50-4. PubMed ID: 9491969 [TBL] [Abstract][Full Text] [Related]
9. Benzodiazepine screening using EMIT II and TDx: urine hydrolysis pretreatment required. Meatherall R J Anal Toxicol; 1994; 18(7):385-90. PubMed ID: 7861751 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the rates of hydrolysis of lorazepam-glucuronide, oxazepam-glucuronide and tamazepam-glucuronide catalyzed by E. coli beta-D-glucuronidase using the on-line benzodiazepine screening immunoassay on the Roche/Hitachi 917 analyzer. Dou C; Bournique JS; Zinda MK; Gnezda M; McNally AJ; Salamone SJ J Forensic Sci; 2001 Mar; 46(2):335-40. PubMed ID: 11305436 [TBL] [Abstract][Full Text] [Related]
11. Identification of urinary benzodiazepines and their metabolites: comparison of automated HPLC and GC-MS after immunoassay screening of clinical specimens. Valentine JL; Middleton R; Sparks C J Anal Toxicol; 1996 Oct; 20(6):416-24. PubMed ID: 8889678 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of abalone β-glucuronidase substitution in current urine hydrolysis procedures. Malik-Wolf B; Vorce S; Holler J; Bosy T J Anal Toxicol; 2014 Apr; 38(3):171-6. PubMed ID: 24488113 [TBL] [Abstract][Full Text] [Related]
13. Detection of benzodiazepine intake in therapeutic doses by immunoanalysis of urine: two techniques evaluated and modified for improved performance. Beck O; Lafolie P; Hjemdahl P; Borg S; Odelius G; Wirbing P Clin Chem; 1992 Feb; 38(2):271-5. PubMed ID: 1541010 [TBL] [Abstract][Full Text] [Related]
14. Comparison between the CEDIA and EMIT II immunoassays for the determination of benzodiazepines. Way BA; Walton KG; Koenig JW; Eveland BJ; Scott MG Clin Chim Acta; 1998 Mar; 271(1):1-9. PubMed ID: 9564553 [TBL] [Abstract][Full Text] [Related]
15. Simultaneous extraction of selected benzodiazepines and benzodiazepine-glucuronides from urine by immunoadsorption. Franzelius C; Ackermann I; Deinl I; Angermaier L; Machbert G J Anal Toxicol; 1998 Sep; 22(5):359-62. PubMed ID: 9737329 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of four immunoassay screening kits for the detection of benzodiazepines in urine. DeRienz RT; Holler JM; Manos ME; Jemionek J; Past MR J Anal Toxicol; 2008; 32(6):433-7. PubMed ID: 18652750 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of a Benzodiazepine Immunoassay for Urine Drug Testing in Clinical Specimens. Ge M; Alabi A; Kelner MJ; Fitzgerald RL; Suhandynata RT J Appl Lab Med; 2024 Nov; 9(6):964-976. PubMed ID: 39163145 [TBL] [Abstract][Full Text] [Related]
19. [The determination of lorazepam in human urine by gas chromatography/nitrogen-phosphorus detector]. Jiang ZL; Tan JY; Yao LJ; Xing LM Se Pu; 2001 Jul; 19(4):341-3. PubMed ID: 12545496 [TBL] [Abstract][Full Text] [Related]
20. Commentary on: Dou C, Bournique J, Zinda M, Gnezda M, Nally A, Salamone S. Comparison of rates of hydrolysis of lorazepam-glucuronide, oxazepam-glucuronide and temazepam-glucuronide catalyzed by E. coli beta-glucuronidase using the on-line benzodiazepine screening immunoassay on the Roche/Hitachi 917 analyzer. O'Neal CL; Poklis A J Forensic Sci; 2002 Mar; 47(2):427-8. PubMed ID: 11908630 [No Abstract] [Full Text] [Related] [Next] [New Search]